CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care.

Cardinal Health forecast double-digit growth in earnings for the fiscal year 2026, despite a hit of $200 million to $300 million due to extreme tariff rates, the drug distributor said on Thursday. The ...

Cardinal Health said on Thursday its diverse global footprint is not "bulletproof" to extreme tariff rates, as the drug distributor expects a hit of $200 million to $300 million in gross costs in ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.

Ohio's largest company doesn't expect much impact from President Trump's tariffs in the final quarter of this fiscal year.

Q3 2025 Management View CEO Jason Hollar announced strong third-quarter results, emphasizing the momentum built over recent years and the resilience of their business model. The performance was ...

Hello, and welcome to the Third Quarter Fiscal Year 2025 Cardinal Health Incorporated Earnings Conference Call. My name is George, and I'll be the coordinator for today's event. Please note, this ...

In the Vatican, final preparations for the conclave are underway. Meanwhile, some Vatican journalists report that the health ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q1 CY2025, with sales flat year on year at $54.88 ...

Cardinal Health’s Mike Brown, vice president of managed services, and Michelle Dalton, regional director of account ...

CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care." ...

In the Vatican, final preparations are underway before the conclave. Meanwhile, reports from some Vatican journalists ...